ABLE Financial Group’s Eli Lilly LLY Stock Holding History

ABLE Financial Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$770K	Sell	837 -15	-2%	-$15.2K	0.15%	106
2025 Q4	$916K	Buy	852 +6	+0.7%	+$5.74K	0.19%	89
2025 Q3	$645K	Sell	846 -119	-12%	-$88.6K	0.14%	108
2025 Q2	$752K	Sell	965 -32	-3%	-$24.9K	0.18%	97
2025 Q1	$823K	Sell	997 -13	-1%	-$10.8K	0.23%	79
2024 Q4	$780K	Sell	1,010 -29	-3%	-$24K	0.23%	79
2024 Q3	$920K	Buy	1,039 +81	+8%	+$72.8K	0.28%	63
2024 Q2	$867K	Buy	958 +55	+6%	+$44K	0.31%	59
2024 Q1	$702K	Buy	903 +83	+10%	+$59.1K	0.28%	66
2023 Q4	$478K	Buy	820 +123	+18%	+$71.8K	0.21%	87
2023 Q3	$374K	Sell	697 -65	-9%	-$33.5K	0.19%	94
2023 Q2	$357K	Buy	762 +91	+14%	+$38.2K	0.18%	87
2023 Q1	$230K	Buy	+671	New	+$226K	0.15%	114

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ABLE Financial Group's LLY Position: Q1 2026 in Review

ABLE Financial Group reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $15.2K and leaving 837 shares worth $770K. The position accounts for 0.15% of the portfolio, ranked #106.

ABLE Financial Group first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $920K in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

ABLE Financial Group held 837 shares of Eli Lilly worth $770K as of Q1 2026.
ABLE Financial Group sold 15 Eli Lilly shares in Q1 2026, an estimated $15.2K.
Eli Lilly made up 0.15% of ABLE Financial Group's portfolio in Q1 2026, its #106 holding.
ABLE Financial Group first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
ABLE Financial Group's Eli Lilly position peaked at $920K in Q3 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ABLE Financial Group's 13F filing for Q1 2026, filed 21 Apr 2026.